These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8237829)

  • 1. Pharmacokinetics of amiodarone: implications for drug therapy.
    Roden DM
    Am J Cardiol; 1993 Nov; 72(16):45F-50F. PubMed ID: 8237829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms underlying variability in response to drug therapy: implications for amiodarone use.
    Roden DM
    Am J Cardiol; 1999 Nov; 84(9A):29R-36R. PubMed ID: 10568657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone: historical development and pharmacologic profile.
    Singh BN
    Am Heart J; 1983 Oct; 106(4 Pt 2):788-97. PubMed ID: 6351575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of amiodarone.
    Latini R; Tognoni G; Kates RE
    Clin Pharmacokinet; 1984; 9(2):136-56. PubMed ID: 6370540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacology and pharmacokinetics of amiodarone.
    Freedman MD; Somberg JC
    J Clin Pharmacol; 1991 Nov; 31(11):1061-9. PubMed ID: 1753010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of the newer antiarrhythmic agents.
    Gillis AM; Kates RE
    Clin Pharmacokinet; 1984; 9(5):375-403. PubMed ID: 6437721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of amiodarone.
    Haffajee CI
    Clin Cardiol; 1987 Jul; 10(7 Suppl 1):I6-9. PubMed ID: 3078155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetic investigation for optimization of amiodarone therapy in Japanese patients.
    Araki R; Yukawa E; Nakashima MN; Fukuchi H; Sasaki H; Yano K; Nakashima M
    Ther Drug Monit; 2011 Dec; 33(6):750-6. PubMed ID: 22105593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral amiodarone: historical overview and development.
    Pollak PT
    Pharmacotherapy; 1998; 18(6 Pt 2):121S-126S. PubMed ID: 9855344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous amiodarone: pharmacology, pharmacokinetics, and clinical use.
    Chow MS
    Ann Pharmacother; 1996 Jun; 30(6):637-43. PubMed ID: 8792951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamic effects of amiodarone in plasma of ponies after single intravenous administration.
    Trachsel D; Tschudi P; Portier CJ; Kuhn M; Thormann W; Scholtysik G; Mevissen M
    Toxicol Appl Pharmacol; 2004 Feb; 195(1):113-25. PubMed ID: 14962511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the pharmacokinetics and bioavailability of intravenously and orally administered amiodarone in horses.
    De Clercq D; Baert K; Croubels S; van Loon G; Maes A; Tavernier R; Deprez P; De Backer P
    Am J Vet Res; 2006 Mar; 67(3):448-54. PubMed ID: 16506906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of long-term oral amiodarone therapy.
    Pollak PT; Bouillon T; Shafer SL
    Clin Pharmacol Ther; 2000 Jun; 67(6):642-52. PubMed ID: 10872646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and body distribution of amiodarone and desethylamiodarone in rats after intravenous administration.
    Plomp TA; Wiersinga WM; van Rossum JM; Maes RA
    In Vivo; 1989; 3(1):33-47. PubMed ID: 2519831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic and clinical pharmacology of amiodarone: relationship of antiarrhythmic effects, dose and drug concentrations to intracellular inclusion bodies.
    Somani P
    J Clin Pharmacol; 1989 May; 29(5):405-12. PubMed ID: 2544634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Physiologically Based Pharmacokinetic Model of Amiodarone and its Metabolite Desethylamiodarone in Rats: Pooled Analysis of Published Data.
    Lu JT; Cai Y; Chen F; Jia WW; Hu ZY; Zhao YS
    Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):689-703. PubMed ID: 26254911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population modelling to describe pharmacokinetics of amiodarone in rats: relevance of plasma protein and tissue depot binding.
    Campos Moreno E; Merino Sanjuán M; Merino V; Nácher A; Martín Algarra RV; Casabó VG
    Eur J Pharm Sci; 2007 Feb; 30(2):190-7. PubMed ID: 17218087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and body distribution of amiodarone and desethylamiodarone in rats after oral administration.
    Plomp TA; Wiersinga WM; Van Rossum JM; Maes RA
    In Vivo; 1987; 1(5):265-79. PubMed ID: 2979794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of intravenous amiodarone in the management of cardiac arrhythmias.
    Desai AD; Chun S; Sung RJ
    Ann Intern Med; 1997 Aug; 127(4):294-303. PubMed ID: 9265430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amiodarone and desethylamiodarone concentrations in plasma and tissues of surgically treated patients on long-term oral amiodarone treatment.
    Plomp TA; Hauer RN; Robles de Medina EO
    In Vivo; 1990; 4(2):97-100. PubMed ID: 2129806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.